◆英語タイトル：Aurinia Pharmaceuticals Inc (AUP) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclosporin ophthalmic solution. It serves the needs of patients and physicians by providing access to therapeutic options and disease awareness. The company has operations in Canada and the US. Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia, Canada.
Aurinia Pharmaceuticals Inc Key Recent Developments
Mar 02,2021: Aurinia Pharmaceuticals to Present at Three Upcoming March Investor Conferences
Feb 24,2021: Aurinia reports fourth quarter and full year 2020 financial results and recent operational highlights
Feb 23,2021: Earnings Preview: Aurinia Pharmaceuticals
Feb 18,2021: Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Feb 17,2021: Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021
This comprehensive SWOT profile of Aurinia Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aurinia Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Aurinia Pharmaceuticals Inc – Key Information
Aurinia Pharmaceuticals Inc – Overview
Aurinia Pharmaceuticals Inc – Key Employees
Aurinia Pharmaceuticals Inc – Key Employee Biographies
Aurinia Pharmaceuticals Inc – Key Operational Heads
Aurinia Pharmaceuticals Inc – Major Products and Services
Aurinia Pharmaceuticals Inc – History
Aurinia Pharmaceuticals Inc – Company Statement
Aurinia Pharmaceuticals Inc – Locations And Subsidiaries
Aurinia Pharmaceuticals Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Aurinia Pharmaceuticals Inc – Business Description
Aurinia Pharmaceuticals Inc – Corporate Strategy
Aurinia Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Aurinia Pharmaceuticals Inc – Strengths
Aurinia Pharmaceuticals Inc – Weaknesses
Aurinia Pharmaceuticals Inc – Opportunities
Aurinia Pharmaceuticals Inc – Threats
Aurinia Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Aurinia Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Aurinia Pharmaceuticals Inc, Key Information
Aurinia Pharmaceuticals Inc, Key Ratios
Aurinia Pharmaceuticals Inc, Share Data
Aurinia Pharmaceuticals Inc, Major Products and Services
Aurinia Pharmaceuticals Inc, History
Aurinia Pharmaceuticals Inc, Key Employees
Aurinia Pharmaceuticals Inc, Key Employee Biographies
Aurinia Pharmaceuticals Inc, Key Operational Heads
Aurinia Pharmaceuticals Inc, Other Locations
Aurinia Pharmaceuticals Inc, Subsidiaries
Aurinia Pharmaceuticals Inc, Key Competitors
Aurinia Pharmaceuticals Inc, SWOT Analysis
Aurinia Pharmaceuticals Inc, Ratios based on current share price
Aurinia Pharmaceuticals Inc, Annual Ratios
Aurinia Pharmaceuticals Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Aurinia Pharmaceuticals Inc (AUP)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら